Nuvalent (NUVL) Insider Trading & Ownership $76.02 -0.11 (-0.14%) Closing price 04:00 PM EasternExtended Trading$76.03 +0.01 (+0.01%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nuvalent (NASDAQ:NUVL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$228.29M Get NUVL Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvalent stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NUVL Insider Buying and Selling by Quarter Nuvalent Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2025James Richard PorterCEOSell27,000$75.42$2,036,340.00 8/7/2025Henry E PelishInsiderSell5,500$74.85$411,675.00 7/16/2025Alexandra BalcomCFOSell14,700$85.10$1,250,970.00 7/15/2025Alexandra BalcomCFOSell5,300$83.50$442,550.00 7/15/2025James Richard PorterCEOSell27,000$82.27$2,221,290.00 7/10/2025Henry E PelishInsiderSell5,500$79.98$439,890.00 7/9/2025Henry E PelishInsiderSell2,145$81.16$174,088.20 6/27/2025Alexandra BalcomCFOSell20,000$80.02$1,600,400.00 6/27/2025Henry E PelishInsiderSell2,170$79.92$173,426.40 6/25/2025Henry E PelishInsiderSell8,630$79.87$689,278.10 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/6/2025Henry E PelishInsiderSell200$79.82$15,964.00 4/15/2025James Richard PorterCEOSell27,000$68.94$1,861,380.00 3/17/2025James Richard PorterCEOSell27,000$75.87$2,048,490.00 2/24/2025Matthew ShairDirectorSell2,000$78.43$156,860.00 2/18/2025James Richard PorterCEOSell27,000$78.46$2,118,420.00 1/27/2025Matthew ShairDirectorSell2,000$82.79$165,580.00 1/15/2025James Richard PorterCEOSell27,000$75.99$2,051,730.00 1/6/2025Alexandra BalcomCFOSell4,016$79.68$319,994.88 1/6/2025Henry E PelishInsiderSell2,483$79.68$197,845.44 1/6/2025James Richard PorterCEOSell17,301$79.68$1,378,543.68 12/23/2024Matthew ShairDirectorSell2,000$83.78$167,560.00 12/16/2024James Richard PorterCEOSell27,000$86.61$2,338,470.00 11/25/2024Matthew ShairDirectorSell2,000$96.22$192,440.00 10/31/2024Alexandra BalcomCFOSell10,000$89.19$891,900.00 10/28/2024Matthew ShairDirectorSell2,000$91.73$183,460.00 10/22/2024James E FlynnDirectorSell2,000,000$97.75$195,500,000.00 10/15/2024James Richard PorterCEOSell27,000$102.28$2,761,560.00 10/1/2024Darlene NociInsiderSell5,000$101.74$508,700.00 9/30/2024Alexandra BalcomCFOSell10,000$101.06$1,010,600.00 9/23/2024Matthew ShairDirectorSell2,000$102.75$205,500.00 9/16/2024Henry E PelishInsiderSell32,795$98.92$3,244,081.40 9/9/2024Deborah Ann MillerInsiderSell3,000$88.18$264,540.00 9/3/2024Darlene NociInsiderSell5,000$84.43$422,150.00 8/30/2024Alexandra BalcomCFOSell10,000$84.23$842,300.00 (Data available from 1/1/2013 forward) NUVL Insider Trading Activity - Frequently Asked Questions Who is on Nuvalent's Insider Roster? The list of insiders at Nuvalent includes Alexandra Balcom, Andrew A F Hack, Anna Protopapas, Christopher Durant Turner, Darlene Noci, Deborah Ann Miller, Emily Conley, Henry E Pelish, James E Flynn, James Richard Porter, and Matthew Shair. Learn more on insiders at NUVL. What percentage of Nuvalent stock is owned by insiders? 10.20% of Nuvalent stock is owned by insiders. Learn more on NUVL's insider holdings. Which Nuvalent insiders have been selling company stock? The following insiders have sold NUVL shares in the last 24 months: Alexandra Balcom ($10,182,714.88), Andrew A F Hack ($64,037,600.00), Anna Protopapas ($378,350.00), Christopher Durant Turner ($432,049.80), Darlene Noci ($6,712,950.00), Deborah Ann Miller ($3,358,220.00), Emily Conley ($1,074,856.68), Henry E Pelish ($6,239,588.54), James E Flynn ($195,500,000.00), James Richard Porter ($18,816,223.68), and Matthew Shair ($34,186,567.82). How much insider selling is happening at Nuvalent? Insiders have sold a total of 3,971,069 Nuvalent shares in the last 24 months for a total of $340,919,121.40 sold. Nuvalent Key ExecutivesDr. James R. Porter Ph.D. (Age 48)CEO, President & Director Compensation: $1.05MProf. Matthew D. Shair Ph.D. (Age 55)Founder, Head of Scientific Advisory Board & Director Compensation: $239kMs. Alexandra Balcom CPA (Age 39)M.B.A., CFO & Treasurer Compensation: $689.41k3 recent tradesDr. Christopher D. Turner M.D. (Age 55)Chief Medical Officer Compensation: $750.97kDr. Benjamin Lane Ph.D.Senior Vice President of Technical OperationsMs. Deborah Ann Miller J.D. (Age 48)Ph.D., Chief Legal Officer & Secretary Compensation: $595.96kMr. Matthew MetivierSenior Vice President of Human ResourcesMs. Darlene Noci (Age 46)Chief Development Officer Mr. Henry Pelish Ph.D.Senior Vice President of Drug DiscoveryMr. John Soglia Ph.D.Senior Vice President of Translational Development More Insider Trading Tools from MarketBeat Related Companies TEVA Insider Buying SMMT Insider Buying GMAB Insider Buying VTRS Insider Buying MRNA Insider Buying BBIO Insider Buying VRNA Insider Buying ELAN Insider Buying BPMC Insider Buying ROIV Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:NUVL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access